See every side of every news story
Published loading...Updated

Novo Nordisk slashes Wegovy prices through direct-to-consumer pharmacy

  • Novo Nordisk is cutting the price of Wegovy to $499 per month, which is a 60% discount from the list price of $1,349.02.
  • The new pricing applies to uninsured patients or those with commercial insurance that does not cover obesity treatments, effective immediately.
  • Eli Lilly reduced the price of Zepbound to $399 for its lowest dose, through a similar program.
  • The U.S. Food and Drug Administration has removed semaglutide, the active ingredient in both drugs, from its drug shortage list, allowing for more supply availability.
Insights by Ground AI
Does this summary seem wrong?

24 Articles

All
Left
7
Center
8
Right
3
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 44% of the sources are Center
44% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Latest News broke the news in on Wednesday, March 5, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.